AMIRES participated in next interactive EPIC Technology Meeting on Biosensors, occured on 11 May 2020 and here are some of the highlights.
One of the key topics discussed was development of various Point-of-care (POC) tests for timely and reliable detection of COVID-19. Laura Lechuga, the Head of the Nanobiosensors & Bioanalytical Applications at ICN2 presented a solution, which is cheaper POC nanophotonics-based version of the Nucleic Acid Amplification Tests (RT-PCR) laboratory testing. While establishing a manufacturing process of the nanophotonic-based biosensor, some of the highlighted challenges which are quite common for development of biosensors are: packaging and biofunctionalization. As demonstrated by presentations of industrial partners (Surfix, PIXAPP, LIGENTEC), Europe’s manufacturing base is ready to address such challenge. One of the recent examples of strengthened manufacturing capability of Europe is the MedPhab H2020 funded initiative, which sets up Europe’s first manufacturing pilot line for photonics-based medical diagnostic devices and instruments to accelerate their development and commercialization.
From the technologies, integrated photonics was presented as a key enabler of the progress in biosensor research and development. Surface plasmon resonance imaging (NESPRI) was praised as a reliable sensing technology method. It has been successfully applied also in ULTRAPLACAD project, which recently developed an ULTRAsensitive PLAsmonic device for early Cancer Diagnosis.
For more information on the agenda and presentations click HERE